Chugai Pharmaceutical Company is a Japanese drug manufacturer owned by Hoffmann-La Roche with 62% control as of June 30th, 2014. Its headquarters is in Tokyo, and its current representative director and chairman is Osamu Nagayama while Tatsuro Kosaka serves as its representative director, president, and CEO.